Merck snags Elanco’s coccidiosis treatment for US$55 million Posted on February 20, 2020 The sale Vecoxan marks Elanco’s third product divestment in North America this year + Read More
Merck snags Elanco’s coccidiosis treatment for $55 million Posted on February 20, 2020February 20, 2020 The sale of Vecoxan marks Elanco’s third product divestment in North America this year + Read More